Not Yet Recruiting PHASE1 INTERVENTIONAL 1-arm NCT06925607

Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

A Phase l Clinical Study Evaluating the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Conditions Radiation Proctitis

Interventions Mesenchymal Stem Cells (MSCs)

Updated 1 time since 2025 Last updated: Apr 7, 2025 Started: Apr 30, 2025 Primary completion: Mar 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06925607, this PHASE1 trial focuses on Radiation Proctitis and remains actively recruiting participants. Sponsored by Jiangsu Topcel-KH Pharmaceutical Co., Ltd., it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE1 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Data source: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.